Edap Tms (NASDAQ:EDAP) Coverage Initiated at StockNews.com

Analysts at StockNews.com started coverage on shares of Edap Tms (NASDAQ:EDAP) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

Edap Tms Stock Performance

NASDAQ:EDAP opened at $2.39 on Wednesday. The business’s 50-day moving average price is $2.43 and its two-hundred day moving average price is $2.59. Edap Tms has a twelve month low of $2.00 and a twelve month high of $8.50. The stock has a market cap of $88.68 million, a P/E ratio of -3.68 and a beta of 0.37. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08.

Institutional Trading of Edap Tms

Several institutional investors and hedge funds have recently modified their holdings of the business. BNP Paribas Financial Markets raised its holdings in shares of Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after acquiring an additional 4,400 shares in the last quarter. Orion Capital Management LLC raised its holdings in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after buying an additional 6,600 shares in the last quarter. Illumine Investment Management LLC purchased a new position in shares of Edap Tms during the 4th quarter valued at about $50,000. Rock Springs Capital Management LP raised its holdings in shares of Edap Tms by 1.5% during the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock valued at $3,518,000 after buying an additional 23,800 shares in the last quarter. Finally, Millennium Management LLC raised its holdings in shares of Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after buying an additional 33,558 shares in the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.